openPR Logo
Press release

Epigenetics Market Key Players, Supply Chain and Analysis 2018-2027

08-07-2018 04:37 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Fact.MR

/ PR Agency: Fact.MR
Epigenetics Market Key Players, Supply Chain and Analysis

Epigenetics Research Funding to Radiate a Cohort of Opportunities for Chronic Disease Treatments

Increasing funding for research and development for discovering therapeutic solutions continues to remain instrumental in product development pertaining to epigenetics space. With growing concerns regarding prevalence of chronic diseases such as cancer, diabetes and other metabolic diseases, organizations such as the National Institute of Health (NIH), National Cancer Institute (NCI) and the International Human Epigenome Consortium (IHEC) have encouraged advanced research in epigenetics field by undertaking new research initiatives such as the Epidemiology and Genomics Research Program. This factor has largely facilitated the novel therapeutic products, in turn supporting the epigenetics market.

Request Brochure of this Report@ https://www.factmr.com/connectus/sample?flag=B&rep_id=435

Epigenetics Gaining Ground in Cancer Therapeutics

Pervasiveness of epigenetics in biology has facilitated study of various alterations in gene expression that has played a vital role in understanding development of cancer cells and developing appropriate medications. Increasing prevalence of cancer cases worldwide have fuelled the need for advanced therapeutics to treat the chronic disease, which has influenced the growth of epigenetics market. For instance, World Health Organization (WHO) estimates that the cancer mortality rate in India has surpassed 79 per 100,000 deaths in the coming years. Likewise, American Cancer Society reveals that in 2017, United States reflected about 1,688,780 cancer cases and this figure is likely to increase in the future owing to improper lifestyle and high percentage of smoking and drinking. That said, the demand for cancer treatment and novel therapeutics has evolved to the next level using epigenetic research, which is likely to support the epigenetics market growth in the coming years.

Increasing Cardiovascular Diseases to Spearhead Epigenetics Demand

Prevalence of cardiovascular diseases (CVDs) was high in the past and is expected to further grow in the coming years owing to improper lifestyle and eating patterns. For instance, according to European Cardiovascular Disease Statistics, in 2017, cardiovascular diseases accounted for around 45 percent of deaths in the European countries. Japan is no exception to this, as deaths owing to heart related disorders have risen in the country, making it a subject of concern and high importance for medical practitioners there. Cardiovascular diseases have become pandemic with unhealthy lifestyle and excess consumption of food. Pervasiveness of this metabolic syndrome can be well addressed using novel therapies with epigenetics as their base. That said, increasing funding for research on therapies based on epigenetics for treating CVDs is expected to push the growth of the epigenetics market in the years to follow.

Epigenetics Facilitating New Generation of Diagnostics

Modifications in epigenetics are stable and offer strong signals acting as biomarkers for diseases that can be measured and mapped using HMCP platforms. Epigenetics biomarkers are largely specific for tissue type and disease state. According to scientific researchers, epigenetics can provide platforms for early detection of diseases as they can precede alterations in genetics. Minimally invasive techniques in combination with epigenetics platforms can provide informative tools that can facilitate swift and accurate diagnosis of diseases. With epigenetics as a novel diagnostic platform, a radical approach toward wellbeing management and long-term health can be envisaged allowing implementation of tailored clinical interventions, making diseases not inevitable, but optional.

Request TOC of this Report@ https://www.factmr.com/connectus/sample?flag=T&rep_id=435

Errors Causing Misleading Results in DNA-seq – A Critical Challenge

Albeit its high potential in diagnosis and development of novel therapeutics, epigenetics are associated with errors, especially with respect to the DIP-seq, a widely used method. Different cells in human body use different gene groups. This necessitates the use of additional signals in order to control the respective gene type used for that particular cell. DNA-seq, being attached to chemical groups processing such signals, is likely to make error in the epigenetic code, which can lead to misleading results. This aspect is likely to challenge the epigenetics market.

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: www.factmr.com/
Follow Us on Linkedin: www.linkedin.com/company/factmr/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Epigenetics Market Key Players, Supply Chain and Analysis 2018-2027 here

News-ID: 1167207 • Views: 112

More Releases from Fact.MR

Global Truck Cranes Market Forecast, Trend Analysis & Competition Tracking durin …
According to Fact.MR, the truck cranes market is foreseen to register volume sales of over 9,300 Units in 2018, up by370 units in 2017. Overall growth of the market can be attributed to, Increasing investments in infrastructure-oriented development Buoyancy in utilities and power distribution sectors where truck cranes find significant application OEMs’ efforts to expand truck crane product portfolio with enhanced operational efficiency While demand for construction and heavy-duty equipment remains perennial, Fact.MR says
North America Accounts for Over 30% of Overall Aluminum Powder Sales, finds Fact …
According to a recently published Fact. MR report, global sales of aluminum powder in 2018 exceeded 110 Thousand tons and is expected to grow at moderate rate in the forecast period. According to the study, North America will maintain its supremacy in the market for aluminum powder, owing to the widespread demand from the region's automotive and aerospace sectors. The rising demand of lightweight materials in the automotive and aerospace
“Petroleum-Based to Bio-Based Propylene Glycol” is a Key Trend, Finds Fact.M …
The recently published research report by Fact.MR regarding the global propylene glycol market includes product classification and current synopsis along with product upgrades and innovations. The propylene glycol market was pegged at more than 2,500 Thousand Tons in 2018, and the global market is likely to witness a strong growth rate during the forecast period on the backdrop of increasing building & construction activities along with expanding production capacities of
Isocyanates Manufacturers Leveraging Advancements and Modernization in the Adhes …
The recently published report by Fact.MR regarding the global isocyanates market includes product classification and current synopsis along with product upgrades and innovations. Increasing demand from the building and automotive industries is increasing the polyurethane consumption in numerous consumer and industrial applications. Moreover, the thriving pharmaceutical industries, and isocyanates advantageous characteristics are the primary drivers for development in the worldwide isocyanate market. Burgeoning isocyanate acceptance for use in newer vertical

All 5 Releases


More Releases for Epigenetics

Epigenetics Market | Size | Share | Global Industry Report 2018 - 2024
A Global Report On Epigenetics Market With Analysis And Past, Present And Future Trends Epigenetics are emerged as to include any process that alters gene activity without changing the DNA sequence. It is basically a study of heritable changes in gene expression which involves the change in phenotype without changing genotype. Epigenetic changes are affected by various factors like lifestyle, environment, age and state of disease. Epigenetic modifications can manifest
Epigenetics Market estimate to reach $1,321 million by 2023
"Epigenetics has provided hope for advanced cancer treatment, and is expected to be the one of the most effective treatment options for diseases in future, especially cancer. The rise in awareness about epigenetic factors and their role in developmental & disease biology are anticipated to create lucrative opportunities in the forecast period." According to a new report published by Allied Market Research, titled, "Epigenetics Market by Product, Application, and End User:
Epigenetics Market Objectives and Detailed Study 2018
WiseGuyReports.Com Publish a New Market Research Report On –“ Epigenetics Market Objectives and Detailed Study 2018”. The Epigenetics industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Epigenetics market size to maintain the average annual growth rate of 14.47% from 570 million $ in 2014 to 855 million $ in 2017, The analysts believe that in the next few years, Epigenetics market
Epigenetics Market: Restraint,Competitor
Increasing research to study the epigenetics of the genome (study called epigenomics) is expected to boost growth of the epigenetics market over the forecast period. Genome-wide epigenetic studies play an important role in the diagnostics of human diseases. Moreover, implementation of epigenetics for oncology research is estimated to propel the growth of epigenetics market. For instance, Constellation Pharmaceuticals, in April 2018, invested US$ 100 million for development of cancer epigenetics
Epigenetics Market - Development of therapeutic drugs 2025
Global Epigenetics Market: Overview The global epigenetics market is expected to grow at a fast paced CAGR in the next few years, owing to factors such as extensive use in the research of developmental and disease process, and growing importance of Life Science. Increasing incidences of cancer and other life threatening diseases will also drive the growth of the global epigenetics market. Epigenetic changes are extensively used in cancer research for
Epigenetics Market : Scenario and Forecast 2017 - 2025
Global Epigenetics Market: Overview The global epigenetics market is expected to grow at a fast paced CAGR in the next few years, owing to factors such as extensive use in the research of developmental and disease process, and growing importance of Life Science. Increasing incidences of cancer and other life threatening diseases will also drive the growth of the global epigenetics market. Epigenetic changes are extensively used in cancer research for